GENE ONLINE|News &
Opinion
Blog

JAK Inhibitor
Licensing JAK Inhibitor
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
M&A Oncology
GSK to Acquire Biopharmaceutical Company Sierra Oncology for $1.9B
2022-04-17
Technology HUMIRA
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
Trials & Approvals FDA Approval
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Trials & Approvals Atopic Dermatitis
Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
2020-11-08
Trials & Approvals Alopecia Areata
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
Japan
Torii Pharma’s Corectim Ointment Features in Japan’s NHI Drug Price List
2020-04-26
Trials & Approvals IL-31
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top